Healthcare
Topics also related to Healthcare:
Merck signs $5 bln share buyback agreement with Goldman Sachs
May 21 - Merck & Co Inc said it has entered into a $5 billion share repurchase agreement with Goldman Sachs Group Inc, as the drug giant looks to prop up shareholder value in face of stiff competition from makers of less-costly generics.
UPDATE 1-Healthcare workers strike at five California public hospitals
SAN FRANCISCO, May 21 - Thousands of healthcare workers walked off the job at the University of California's five medical centers on Tuesday, delaying emergency care, surgeries, diagnostic procedures and other medical treatment throughout the state.
CORRECTED-Amag investigates anemia drug after report of death in Switzerland
(Corrects headline to "investigates." Amag did not say the drug caused the fatality.)
Roche, Sigma teamed up for failed Life Technologies bid -sources
NEW YORK, May 21 - Roche Holding AG teamed up with Sigma-Aldrich Corp to make an unsuccessful bid for Life Technologies Corp earlier this year, people familiar with the matter said.
Amag says anemia drug caused fatal reaction in Switzerland
May 21 - Amag Pharmaceuticals Inc said its marketing partner in Switzerland, Takeda Pharmaceutical Co Ltd, is recalling a batch of Amag's anemia drug, Rienso, because of a death and several cases of hypersensitivity.
| Healthcare | ||
| Johnson & Johnson | $88.59 | +0.66% |
| Pfizer Inc | $28.78 | +0.28% |
| Merck & Co Inc | $47.33 | +4.69% |
Markets
- Sectors
- U.S.
- Europe
- Asia
Sector Summary
| Energy |  +0.30% |
| Basic Materials | +0.81% |
| Industrials | +0.39% |
| Cyclical Goods & Services | +0.34% |
| Non-Cyclical Goods & Services | +0.04% |
| Financials | +0.30% |
| Healthcare | +0.78% |
| Technology | +0.02% |
| Telecoms | +0.04% |
| Utilities | +0.20% |
| DOW | 15,387.58 | +52.30 |
+0.34% |
| S&P 500 | 1,669.16 | +2.87 |
+0.17% |
| NASDAQ | 3,502.12 | +5.69 |
+0.16% |
| TR US Index | 151.47 | +0.24 |
+0.16% |
-126.66Upcoming Events
No related earnings announcements are currently scheduled within the next 7 days.
Analyst Research
| Report Title | Price |
|---|---|
|
Provider: GUOTAI JUNAN Securities Co.Ltd
|
$10.00
|
|
Provider: Renaissance Capital
|
$92.00
|
|
Provider: Edison Investment Research
|
$10.00
|
|
Provider: Renaissance Capital
|
$92.00
|
|
Provider: Renaissance Capital
|
$92.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
